No — private label adaptogen serums sold in the United States as cosmetics do not require pre-market FDA approval. Under the Federal Food, Drug, and Cosmetic Act, cosmetics (products intended to cleanse or beautify) are not subject to premarket approval the way drugs are. You are, however, legally responsible for ensuring the product is safe, properly labeled, and not adulterated or misbranded.
The critical regulatory trap for adaptogen serum brands is making drug claims on the label or in marketing copy. A cosmetic claim describes how a product affects appearance: "visibly smooths the look of stressed skin" or "helps skin look more radiant." A drug claim describes a physiological effect: "reduces cortisol-driven inflammation" or "treats stress-induced eczema." The moment you make a drug claim, FDA classifies your product as an unapproved new drug — a serious compliance issue that can result in warning letters, import holds, and product seizures.
Adaptogen language is particularly risky because the mechanism of action language often used in supplement marketing ("helps the body adapt to stress") is a drug claim when applied to a topical cosmetic. Your marketing team needs to be briefed on this distinction before any copy goes live.
Under the Modernization of Cosmetics Regulation Act (MoCRA), signed into law in December 2022, new requirements are phasing in for cosmetic facilities: mandatory facility registration with FDA, product listing, serious adverse event reporting, and substantiated safety data on file. Manufacturers operating in the US are responsible for facility registration; brands are responsible for product listing. If your contract manufacturer is not yet MoCRA-registered, that is a red flag.
For the EU, selling a cosmetic serum requires a Cosmetic Product Safety Report (CPSR) prepared by a qualified safety assessor, product notification in the EU CPNP portal, and a designated EU Responsible Person. The CPSR process typically takes four to eight weeks and costs $500–$2,000 depending on the assessor and the complexity of the formula.
AJ Cosmo Labs encourages all founders using the platform to confirm regulatory compliance steps with their manufacturer and, where needed, an independent regulatory consultant before launch.
Read the full guide on Private Label Adaptogen Skincare Serum Manufacturer Low MOQ →